Brevel

Brevel is a food technology company that develops algae-based protein food ingredients using its proprietary illuminated fermentation platform. The company has developed indoor, sterile, and automated photo-bioreactors that use light-driven fermentation to produce microalgae, unlocking a whole new range of light-dependent ingredients. Brevel platform maximizes yields from microalgae, plant cell culture, yeast, and bacteria, offering stable, scalable, continuous, and cost-effective production with applications across food, pharmaceuticals, cosmetics, and wellness. The company produces in-house brands including Brevel Protein, Brevel Purallis Chlorella biomass, and plant-based lipids. Brevel illuminated fermentation infrastructure is available to companies developing light-dependent ingredients, handling the full journey from benchtop R&D and scale-up through commercial production. Founded in 2016 and headquartered in Israel, Brevel has raised approximately $28.5 million in seed funding from investors including EIC Fund, NevaTeam Ventures, Tet Ventures, Good Startup, Siddhi Capital, and the European Innovation Council.